دورية أكاديمية
A clearer vision: insights into juvenile idiopathic arthritis-associated uveitis.
| العنوان: | A clearer vision: insights into juvenile idiopathic arthritis-associated uveitis. |
|---|---|
| المؤلفون: | M Bani Khalaf I; Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan., Jain H; Department of Medicine, All India Institute of Medical Sciences, Jodhpur, India., Vora NM; Department of Medicine, Terna Speciality Hospital and Research Centre, Navi Mumbai, India., Ul Ain N; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan., Murtaza F; Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan., Ram MD; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Nankani A; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Motwani J; Department of Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan. |
| المصدر: | Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2024 Feb 08; Vol. 37 (2), pp. 303-311. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Baylor Research Foundation Country of Publication: United States NLM ID: 9302033 Publication Model: eCollection Cited Medium: Print ISSN: 0899-8280 (Print) Linking ISSN: 08998280 NLM ISO Abbreviation: Proc (Bayl Univ Med Cent) Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Dallas, Tex. : Baylor Research Foundation, |
| مستخلص: | The aim of this narrative review is to synthesize existing evidence-based knowledge on juvenile idiopathic arthritis-associated uveitis (JIA-U). We highlight epidemiology, pathophysiology, causes and genetics, risk factors, clinical features, diagnosis and screening, laboratory biomarkers, treatment options, trials with recent advances, and research challenges pertaining to JIA-U. The prevalence of JIA-U varies with different JIA subtypes, most frequently associated with the oligoarticular subtype. The risk factors involved in the development of JIA-U include younger age, antinuclear antibody (ANA) positivity, and the oligoarticular subtype of JIA, along with some specific major histocompatibility complex genes. Certain laboratory biomarkers, such as ANA, rheumatoid factor, interferon-λ, erythrocyte sedimentation rate, and transthyretin, have been used in JIA-U diagnosis, progress monitoring, and prognostication. Clinical features of JIA-U can range from asymptomatic to ophthalmic symptoms like redness, blurred vision, decreased visual acuity, hypopyon, and posterior uveitis, which can lead to retinal detachment and macular edema. The management protocol involves topical and systemic steroids, cycloplegics, disease-modifying antirheumatic drugs, biologic drugs, and surgical options. Early detection combined with prompt treatment is crucial to preventing irreversible vision loss in JIA-U. Competing Interests: The authors report no external funding or conflicts of interest. (Copyright © 2024 Baylor University Medical Center.) |
| References: | Arthritis Rheumatol. 2018 Oct;70(10):1685-1694. (PMID: 29732713) Lancet Child Adolesc Health. 2019 Apr;3(4):255-263. (PMID: 30819662) Rheumatology (Oxford). 2013 May;52(5):765-6. (PMID: 23221329) Curr Opin Rheumatol. 2017 Sep;29(5):523-529. (PMID: 28538013) Curr Rheumatol Rep. 2012 Apr;14(2):142-9. (PMID: 22201032) Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. (PMID: 24410427) Arthritis Care Res (Hoboken). 2019 Nov;71(11):1436-1443. (PMID: 30320957) Nat Rev Rheumatol. 2015 Jun;11(6):338-48. (PMID: 25825278) Autoimmun Rev. 2010 Aug;9(10):674-83. (PMID: 20553975) Br J Ophthalmol. 2003 Jul;87(7):879-84. (PMID: 12812891) Children (Basel). 2023 Feb 23;10(3):. (PMID: 36979992) Am J Ophthalmol. 2003 Jun;135(6):867-78. (PMID: 12788128) J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S238-47. (PMID: 20061009) Arthritis Care Res (Hoboken). 2014 Jul;66(7):1073-84. (PMID: 24740981) Am J Ophthalmol. 2002 May;133(5):617-21. (PMID: 11992858) Surv Ophthalmol. 2014 Sep-Oct;59(5):517-31. (PMID: 25130893) J Clin Invest. 2010 Sep;120(9):3073-83. (PMID: 20811163) Arthritis Rheumatol. 2019 Jun;71(6):864-877. (PMID: 31021511) Eye (Lond). 2012 Jan;26(1):17-28. (PMID: 21960067) Acta Ophthalmol. 2017 Aug;95(5):e405-e414. (PMID: 27873479) Arthritis Rheum. 2005 Feb 15;53(1):18-23. (PMID: 15696578) J Rheumatol. 1991 Sep;18(9):1394-7. (PMID: 1757943) Pediatr Rheumatol Online J. 2023 Sep 12;21(1):99. (PMID: 37700264) Br J Ophthalmol. 2005 Apr;89(4):444-8. (PMID: 15774921) Front Pediatr. 2023 Jan 09;10:1091308. (PMID: 36699287) Arthritis Rheum. 2010 Jun;62(6):1824-8. (PMID: 20178126) J Ophthalmic Inflamm Infect. 2018 Oct 16;8(1):17. (PMID: 30327966) Surv Ophthalmol. 2016 Mar-Apr;61(2):197-210. (PMID: 26599495) Invest Ophthalmol Vis Sci. 2013 May 01;54(5):3709-20. (PMID: 23633652) Arthritis Care Res (Hoboken). 2019 Jun;71(6):703-716. (PMID: 31021540) Ocul Immunol Inflamm. 2023 Jul;31(5):1079-1080. (PMID: 35587645) J Rheumatol. 2023 Mar;50(3):300-303. (PMID: 36379581) Ophthalmology. 2005 Jul;112(7):1287-92. (PMID: 15921752) Br J Ophthalmol. 2012 Jan;96(1):140-1. (PMID: 21979899) J Ophthalmic Inflamm Infect. 2015 Dec;5(1):35. (PMID: 26590046) Arthritis Rheumatol. 2018 Jul;70(7):1155-1165. (PMID: 29513936) Trials. 2014 Jan 09;15:14. (PMID: 24405833) Am J Ophthalmol. 2003 May;135(5):676-80. (PMID: 12719076) Paediatr Drugs. 2009;11(4):229-41. (PMID: 19566107) Arthritis Care Res (Hoboken). 2011 Apr;63(4):612-8. (PMID: 21452272) Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):689-692. (PMID: 37114341) Children (Basel). 2021 Jul 27;8(8):. (PMID: 34438537) Am J Ophthalmol. 1996 Aug;122(2):171-82. (PMID: 8694085) Reumatologia. 2020;58(5):277-281. (PMID: 33227093) Commun Biol. 2019 Sep 20;2:348. (PMID: 31552301) Mod Rheumatol. 2019 Mar;29(2):275-286. (PMID: 30686091) J Pediatr. 1992 Jul;121(1):56-60. (PMID: 1625093) Ocul Immunol Inflamm. 2014 Oct;22(5):414-23. (PMID: 24988139) Front Immunol. 2019 Aug 06;10:1793. (PMID: 31447836) Curr Opin Ophthalmol. 2019 May;30(3):179-186. (PMID: 30844943) Expert Rev Clin Immunol. 2019 Jun;15(6):657-666. (PMID: 30874452) Ophthalmology. 2008 Oct;115(10):1833-6. (PMID: 18495247) Curr Opin Ophthalmol. 2010 Nov;21(6):468-72. (PMID: 20729734) Clin Med Res. 2006 Dec;4(4):294-309. (PMID: 17210978) Rheumatol Int. 2015 May;35(5):777-85. (PMID: 25656443) Pediatr Rheumatol Online J. 2015 Jun 02;13:19. (PMID: 26031738) Arthritis Rheum. 2005 Mar;52(3):826-32. (PMID: 15751057) Ther Adv Ophthalmol. 2021 Feb 18;13:2515841420984572. (PMID: 33681703) Acta Ophthalmol. 2011 Sep;89(6):e521-7. (PMID: 21586097) Pediatr Rheumatol Online J. 2019 Apr 11;17(1):15. (PMID: 30975163) J AAPOS. 2008 Dec;12(6):539-45. (PMID: 18789737) J Rheumatol. 2013 Dec;40(12):2088-96. (PMID: 24187099) Arch Ophthalmol. 1986 Jun;104(6):847-51. (PMID: 3521558) Am J Ophthalmol. 2010 Jun;149(6):994-999.e5. (PMID: 20510688) Cell Mol Life Sci. 2009 Oct;66(19):3095-101. (PMID: 19644733) Br J Ophthalmol. 2006 Oct;90(10):1327-8. (PMID: 16980650) Ocul Immunol Inflamm. 2023 Dec;31(10):1997-2000. (PMID: 36657742) Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100, i. (PMID: 25721436) Rheumatol Int. 2012 May;32(5):1121-33. (PMID: 22083610) Pediatr Rheumatol Online J. 2016 Apr 27;14(1):27. (PMID: 27121190) FASEB J. 2000 May;14(7):835-46. (PMID: 10783137) Pediatr Rheumatol Online J. 2021 Aug 21;19(1):132. (PMID: 34419092) J Autoimmun. 2019 Jun;100:75-83. (PMID: 30885419) Ocul Immunol Inflamm. 2013 Jun;21(3):180-91. (PMID: 23713827) Best Pract Res Clin Rheumatol. 2017 Aug;31(4):517-534. (PMID: 29773271) Rheumatology (Oxford). 2002 Dec;41(12):1428-35. (PMID: 12468825) J Cataract Refract Surg. 2009 Apr;35(4):725-31. (PMID: 19304096) Curr Opin Immunol. 1996 Dec;8(6):831-6. (PMID: 8994863) Acta Ophthalmol. 2017 Nov;95(7):741-747. (PMID: 28205413) Br J Ophthalmol. 2002 Jan;86(1):51-6. (PMID: 11801504) Clin Immunol. 2020 Feb;211:108322. (PMID: 31830532) Arthritis Rheum. 1999 Sep;42(9):1843-53. (PMID: 10513798) |
| فهرسة مساهمة: | Keywords: Biologics; disease-modifying antirheumatic drugs; juvenile idiopathic arthritis; juvenile idiopathic arthritis-associated uveitis; uveitis |
| تواريخ الأحداث: | Date Created: 20240212 Latest Revision: 20240213 |
| رمز التحديث: | 20240213 |
| مُعرف محوري في PubMed: | PMC10857453 |
| DOI: | 10.1080/08998280.2024.2305567 |
| PMID: | 38343470 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 0899-8280 |
|---|---|
| DOI: | 10.1080/08998280.2024.2305567 |